174 related articles for article (PubMed ID: 37226874)
1. Reassessing the survival benefit of deceased donor liver transplantation: retrospective cohort study.
Malamon JS; Kaplan B; Jackson WE; Saben JL; Schold JD; Pomfret EA; Pomposelli JJ
Int J Surg; 2023 Sep; 109(9):2714-2720. PubMed ID: 37226874
[TBL] [Abstract][Full Text] [Related]
2. Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study.
Yim SH; Kim DG; Kang M; Koh HH; Choi MC; Min EK; Lee JG; Kim MS; Joo DJ
Int J Surg; 2023 Nov; 109(11):3459-3466. PubMed ID: 37565633
[TBL] [Abstract][Full Text] [Related]
3. Survival Benefit of Living-Donor Liver Transplant.
Jackson WE; Malamon JS; Kaplan B; Saben JL; Schold JD; Pomposelli JJ; Pomfret EA
JAMA Surg; 2022 Oct; 157(10):926-932. PubMed ID: 35921119
[TBL] [Abstract][Full Text] [Related]
4. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
[TBL] [Abstract][Full Text] [Related]
5. Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.
Sharma P; Schaubel DE; Messersmith EE; Guidinger MK; Merion RM
Liver Transpl; 2012 Dec; 18(12):1456-63. PubMed ID: 22965903
[TBL] [Abstract][Full Text] [Related]
6. Sex Disparity in Liver Transplant and Access to Living Donation.
Karnam RS; Chen S; Xu W; Chen C; Elangainesan P; Ghanekar A; McGilvray I; Reichman T; Sayed B; Selzner M; Sapisochin G; Galvin Z; Hirschfield G; Asrani SK; Selzner N; Cattral M; Lilly L; Bhat M
JAMA Surg; 2021 Nov; 156(11):1010-1017. PubMed ID: 34406347
[TBL] [Abstract][Full Text] [Related]
7. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS
Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
[TBL] [Abstract][Full Text] [Related]
8. Impact of major hepatocellular carcinoma policy changes on liver transplantation for hepatocellular carcinoma in the United States.
Shah RH; Chyou D; Goldberg DS
Liver Transpl; 2022 Dec; 28(12):1857-1864. PubMed ID: 35585774
[TBL] [Abstract][Full Text] [Related]
9. A Share 21 model in liver transplantation: Impact on waitlist outcomes.
Nagai S; Chau LC; Kitajima T; Yeddula S; Collins K; Rizzari M; Yoshida A; Abouljoud MS; Moonka D
Am J Transplant; 2020 Aug; 20(8):2184-2197. PubMed ID: 32155314
[TBL] [Abstract][Full Text] [Related]
10. Geographic Disparity in Deceased Donor Liver Transplant Rates Following Share 35.
Bowring MG; Zhou S; Chow EKH; Massie AB; Segev DL; Gentry SE
Transplantation; 2019 Oct; 103(10):2113-2120. PubMed ID: 30801545
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation for hepatocellular carcinoma: the MELD impact.
Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
[TBL] [Abstract][Full Text] [Related]
12. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
Nagai S; Chau LC; Schilke RE; Safwan M; Rizzari M; Collins K; Yoshida A; Abouljoud MS; Moonka D
Gastroenterology; 2018 Nov; 155(5):1451-1462.e3. PubMed ID: 30056096
[TBL] [Abstract][Full Text] [Related]
13. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
[TBL] [Abstract][Full Text] [Related]
14. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
Al Sebayel M; Abaalkhail F; Hashim A; Al Bahili H; Alabbad S; Shoukdy M; Elsiesy H
Transplant Proc; 2015 May; 47(4):1211-3. PubMed ID: 26036556
[TBL] [Abstract][Full Text] [Related]
15. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Kwong AJ; Lai JC; Dodge JL; Roberts JP
Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
[TBL] [Abstract][Full Text] [Related]
16. Racial and ethnic disparities in access to liver transplantation.
Mathur AK; Schaubel DE; Gong Q; Guidinger MK; Merion RM
Liver Transpl; 2010 Sep; 16(9):1033-40. PubMed ID: 20818740
[TBL] [Abstract][Full Text] [Related]
17. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
Trotter JF; Osgood MJ
JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Acuity Circles on Deceased Donor Transplant and Offer Rates Across Model for End-Stage Liver Disease Scores and Exception Statuses.
Wey A; Noreen S; Gentry S; Cafarella M; Trotter J; Salkowski N; Segev D; Israni A; Kasiske B; Hirose R; Snyder J
Liver Transpl; 2022 Mar; 28(3):363-375. PubMed ID: 34482614
[TBL] [Abstract][Full Text] [Related]
19. Survival after live donor versus deceased donor liver transplantation: propensity score-matched study.
Kaltenmeier C; Liu H; Zhang X; Ganoza A; Crane A; Powers C; Gunabushanam V; Behari J; Molinari M
BJS Open; 2024 May; 8(3):. PubMed ID: 38837956
[TBL] [Abstract][Full Text] [Related]
20. Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation.
Raza MH; Kwon Y; Kobierski P; Misra AC; Lim A; Goldbeck C; Etesami K; Kohli R; Emamaullee J
Liver Transpl; 2023 Feb; 29(2):134-144. PubMed ID: 35876731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
